Daniel Ferraz de Campos Mazo

1.5k total citations
59 papers, 911 citations indexed

About

Daniel Ferraz de Campos Mazo is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Daniel Ferraz de Campos Mazo has authored 59 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 37 papers in Hepatology and 12 papers in Surgery. Recurrent topics in Daniel Ferraz de Campos Mazo's work include Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (16 papers) and Liver Disease and Transplantation (12 papers). Daniel Ferraz de Campos Mazo is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (16 papers) and Liver Disease and Transplantation (12 papers). Daniel Ferraz de Campos Mazo collaborates with scholars based in Brazil, United States and Malaysia. Daniel Ferraz de Campos Mazo's co-authors include Flair José Carrilho, Cláudia P. Oliveira, José Tadeu Stefano, Venâncio Avancini Ferreira Alves, Mário Guimarães Pessôa, Rejane Mattar, Vicência Mara Rodrigues de Lima, Joel Faintuch, Benito Pereira Damasceno and Alfredo Damasceno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Daniel Ferraz de Campos Mazo

56 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ferraz de Campos Mazo Brazil	18	603	373	234	148	122	59	911
Danielle Brandman United States	11	807 1.3×	579 1.6×	238 1.0×	34 0.2×	82 0.7×	34	966
Eric Chak United States	10	451 0.7×	463 1.2×	167 0.7×	141 1.0×	59 0.5×	22	1.1k
Peter Holland‐Fischer Denmark	12	405 0.7×	357 1.0×	122 0.5×	55 0.4×	103 0.8×	26	656
Yi Shen China	17	364 0.6×	287 0.8×	74 0.3×	95 0.6×	26 0.2×	49	884
Chiara Zusi Italy	15	326 0.5×	69 0.2×	211 0.9×	102 0.7×	69 0.6×	47	696
Rocco Spagnuolo Italy	15	341 0.6×	107 0.3×	98 0.4×	225 1.5×	69 0.6×	59	777
Jaividhya Dasarathy United States	15	1.1k 1.8×	520 1.4×	416 1.8×	132 0.9×	295 2.4×	27	1.4k
Özlen Atuğ Türkiye	15	332 0.6×	80 0.2×	131 0.6×	113 0.8×	80 0.7×	52	680
Hong Zang China	16	202 0.3×	167 0.4×	166 0.7×	97 0.7×	62 0.5×	39	599
Paolo Ciampalini Italy	21	699 1.2×	192 0.5×	895 3.8×	165 1.1×	188 1.5×	37	1.6k

Countries citing papers authored by Daniel Ferraz de Campos Mazo

Since Specialization

Citations

This map shows the geographic impact of Daniel Ferraz de Campos Mazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ferraz de Campos Mazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ferraz de Campos Mazo more than expected).

Fields of papers citing papers by Daniel Ferraz de Campos Mazo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ferraz de Campos Mazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ferraz de Campos Mazo. The network helps show where Daniel Ferraz de Campos Mazo may publish in the future.

Co-authorship network of co-authors of Daniel Ferraz de Campos Mazo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ferraz de Campos Mazo. A scholar is included among the top collaborators of Daniel Ferraz de Campos Mazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ferraz de Campos Mazo. Daniel Ferraz de Campos Mazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mazo, Daniel Ferraz de Campos, et al.. (2024). Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?. Clinics. 79. 100381–100381. 2 indexed citations

Lawitz, Eric, Mandy Fraessdorf, Guy Neff, et al.. (2024). Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis. Journal of Hepatology. 81(5). 837–846. 25 indexed citations

Mazo, Daniel Ferraz de Campos, et al.. (2022). 15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: A case report. Medicine. 101(35). e30315–e30315. 2 indexed citations

Mazo, Daniel Ferraz de Campos, Adhemar Longatto‐Filho, José Tadeu Stefano, et al.. (2022). African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population. Annals of Hepatology. 27(6). 100728–100728. 11 indexed citations

Ferraz, Maria Lúcia Gomes, Hugo Cheinquer, Giovanni Faria Silva, et al.. (2022). National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents. The Brazilian Journal of Infectious Diseases. 26(4). 102388–102388. 3 indexed citations

D’Albuquerque, Luiz Augusto Carneiro, et al.. (2022). Current aspects of renal dysfunction after liver transplantation. World Journal of Hepatology. 14(1). 45–61. 10 indexed citations

Gomes‐Gouvêa, Michele Soares, Daniel Ferraz de Campos Mazo, Júlio M. Singer, et al.. (2021). Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection. Clinics. 76. e3270–e3270. 5 indexed citations

Oliveira, Cláudia P., et al.. (2021). Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study. Clinics. 76. e3186–e3186. 2 indexed citations

Cintra, Maria Letícia, et al.. (2019). Diarrhea: a missed D in the 4D glucagonoma syndrome. SHILAP Revista de lepidopterología. 9(4). e2019129–e2019129. 4 indexed citations

10.

Mazo, Daniel Ferraz de Campos, et al.. (2019). Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case. Annals of Hepatology. 19(1). 107–112. 9 indexed citations

11.

Paranaguá‐Vezozzo, Denise Cerqueira, Daniel Ferraz de Campos Mazo, Lucas Souto Nacif, et al.. (2018). A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small hepatocellular carcinoma. Hepatoma Research. 4(4). 11–11. 3 indexed citations

12.

Mazo, Daniel Ferraz de Campos, et al.. (2018). Multiple hepatic metastases of cardiac angiosarcoma. Autopsy and Case Reports. 8(4). e2018048–e2018048. 2 indexed citations

13.

Mazo, Daniel Ferraz de Campos, et al.. (2018). Lysosomal Acid Lipase Deficiency Leading to Liver Cirrhosis: a Case Report of a Rare Variant Mutation. Annals of Hepatology. 18(1). 230–235. 3 indexed citations

14.

Stefano, José Tadeu, Luca Miele, Francesca Romana Ponziani, et al.. (2017). Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutrition Metabolism and Cardiovascular Diseases. 28(4). 369–384. 109 indexed citations

15.

Mazo, Daniel Ferraz de Campos, et al.. (2017). HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.. SHILAP Revista de lepidopterología. 15(5). 691–5. 1 indexed citations

16.

Paranaguá‐Vezozzo, Denise Cerqueira, Adriana Ribas Andrade, Daniel Ferraz de Campos Mazo, et al.. (2017). Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C. World Journal of Hepatology. 9(8). 436–436. 20 indexed citations

17.

Farias, Alberto Queiróz, Odílson Marcos Silvestre, Guadalupe García–Tsao, et al.. (2013). Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: A diagnostic accuracy study. Hepatology. 59(3). 1043–1051. 33 indexed citations

18.

Mazo, Daniel Ferraz de Campos, et al.. (2011). Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease. Arquivos de Gastroenterologia. 48(3). 186–189. 35 indexed citations

19.

Oliveira, Cláudia P., Joel Faintuch, Daniel Ferraz de Campos Mazo, et al.. (2010). Pro- and Anti-inflammatory Cytokines in Steatosis and Steatohepatitis. Obesity Surgery. 20(7). 906–912. 29 indexed citations

20.

Mattar, Rejane & Daniel Ferraz de Campos Mazo. (2010). Intolerância à lactose: mudança de paradigmas com a biologia molecular. Revista da Associação Médica Brasileira. 56(2). 230–236. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact